Intimation of new product- ENZYKING SYRUP
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Ltd has announced the launch of a new product called ENZYKING SYRUP on November 12, 2025. The product falls under the digestive enzyme category. The launch is targeted at the domestic market only, with no mention of international expansion. No financial details such as expected revenue, investment, or sales targets have been disclosed in the filing. This is a routine product addition announcement under SEBI Regulation 30.
Marginal near-term impact on the stock as this is a single new product launch with no revenue guidance or financial details provided. Shareholders should wait for future quarterly results to assess actual contribution to sales.